Wolverine Trading, LLC Tg Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Put Options

27 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$17.21 - $25.28 $364,852 - $535,936
-21,200 Reduced 27.97%
54,600 $1.28 Million
Q2 2024

Aug 14, 2024
SELL
$13.32 - $19.19 $41,292 - $59,489
-3,100 Reduced 3.93%
75,800 $1.35 Million
Q1 2024

May 15, 2024
BUY
$13.02 - $21.3 $182,280 - $298,200
14,000 Added 21.57%
78,900 $1.2 Million
Q4 2023

Feb 14, 2024
BUY
$6.68 - $18.81 $60,120 - $169,290
9,000 Added 16.1%
64,900 $1.11 Million
Q3 2023

Nov 15, 2023
SELL
$8.36 - $26.5 $150,480 - $477,000
-18,000 Reduced 24.36%
55,900 $467,000
Q2 2023

Aug 23, 2023
BUY
$15.48 - $35.0 $656,352 - $1.48 Million
42,400 Added 134.6%
73,900 $1.84 Million
Q1 2023

May 15, 2023
BUY
$10.23 - $19.34 $322,245 - $609,210
31,500 New
31,500 $461,000
Q3 2022

Nov 14, 2022
SELL
$4.57 - $8.4 $45,243 - $83,160
-9,900 Reduced 31.63%
21,400 $128,000
Q2 2022

Aug 15, 2022
SELL
$3.74 - $10.66 $11,594 - $33,046
-3,100 Reduced 9.01%
31,300 $135,000
Q1 2022

May 16, 2022
SELL
$7.81 - $20.45 $139,799 - $366,055
-17,900 Reduced 34.23%
34,400 $338,000
Q4 2021

Feb 14, 2022
SELL
$15.2 - $35.51 $13,680 - $31,959
-900 Reduced 1.69%
52,300 $1.01 Million
Q3 2021

Nov 12, 2021
SELL
$21.78 - $40.45 $2,178 - $4,045
-100 Reduced 0.19%
53,200 $1.79 Million
Q2 2021

Aug 06, 2021
BUY
$32.5 - $48.96 $133,250 - $200,736
4,100 Added 8.33%
53,300 $2.01 Million
Q1 2021

May 14, 2021
SELL
$41.61 - $54.3 $1.86 Million - $2.43 Million
-44,800 Reduced 47.66%
49,200 $2.23 Million
Q4 2020

Feb 12, 2021
BUY
$25.27 - $54.9 $778,316 - $1.69 Million
30,800 Added 48.73%
94,000 $4.97 Million
Q3 2020

Nov 13, 2020
SELL
$18.49 - $27.24 $114,637 - $168,888
-6,200 Reduced 8.93%
63,200 $1.65 Million
Q2 2020

Aug 13, 2020
SELL
$8.9 - $21.84 $187,790 - $460,824
-21,100 Reduced 23.31%
69,400 $1.29 Million
Q1 2020

May 11, 2020
SELL
$7.14 - $15.99 $39,270 - $87,945
-5,500 Reduced 5.73%
90,500 $934,000
Q4 2019

Feb 12, 2020
BUY
$5.1 - $11.2 $22,440 - $49,280
4,400 Added 4.8%
96,000 $1.04 Million
Q3 2019

Nov 14, 2019
BUY
$5.38 - $8.99 $150,102 - $250,821
27,900 Added 43.8%
91,600 $518,000
Q2 2019

Aug 20, 2019
SELL
$6.27 - $8.65 $42,009 - $57,955
-6,700 Reduced 9.52%
63,700 $551,000
Q1 2019

May 15, 2019
SELL
$4.02 - $8.04 $38,993 - $77,987
-9,700 Reduced 12.11%
70,400 $566,000
Q4 2018

Feb 14, 2019
SELL
$3.44 - $5.76 $197,800 - $331,200
-57,500 Reduced 41.79%
80,100 $319,000
Q3 2018

Nov 14, 2018
BUY
$5.15 - $14.0 $156,560 - $425,600
30,400 Added 28.36%
137,600 $771,000
Q1 2018

May 15, 2018
BUY
$8.7 - $16.8 $932,639 - $1.8 Million
107,200 New
107,200 $1.52 Million
Q4 2017

Feb 14, 2018
SELL
$7.35 - $12.3 $513,765 - $859,770
-69,900 Closed
0 $0
Q3 2017

Nov 15, 2017
BUY
$10.0 - $12.7 $699,000 - $887,730
69,900
69,900 $828,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
88.3M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email